Alexander Fink

Alexander Fink has had a varied career, beginning in 2018 as an Investor at Curve and a Principal at the Fink Family Office, where they worked closely with their father Lord Stanley Fink. In 2019, they were appointed Executive Director at Project Etopia, and in 2020 they became an Investor at Istidama Limited, an Advisor to the Board at Wise Analytics Group, and a Director at Seneca Learning. In 2021, they were appointed Director at ARGONAUTE RNA LIMITED, and in 2022 they became a Non Executive Director at MitoRx Therapeutics. In 2023, they were appointed Advisor to the Board at QV Bioelectronics and Director at EnsiliTech.

Alexander Fink attended the Merchant Taylors School from 2000 to 2005, where they achieved 3A's & a C in A Levels and 5A*, 5A's & B in GCSE. Alexander then attended the University of York from 2006 to 2008, where they earned a Bachelor of Science in Economics and Finance.